12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers

• Tevogen Bio Holdings (NASDAQ:TVGN) stock rose 55.4% to $1.53 during Monday's pre-market session. The market value of their outstanding shares is at $251.8 million.
• MiNK Therapeutics (NASDAQ:INKT) stock increased by 31.09% to $1.18. The company's market cap stands at $40.9 million.
• Dynatronics (NASDAQ:DYNT) stock increased by 21.69% to $0.57. The company's market cap stands at $2.8 million. As per the press release, Q3 earnings came out 2 days ago.
• Tarsus Pharmaceuticals (NASDAQ:TARS) shares moved upwards by 18.08% to $43.69. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q1 earnings report came out 3 days ago.
• CareCloud (NASDAQ:CCLD) shares increased by 15.07% to $1.45. The company's market cap stands at $23.3 million.
• Fulcrum Therapeutics (NASDAQ:FULC) shares rose 13.78% to $8.5. The market value of their outstanding shares is at $528.3 million. The company's, Q1 earnings came out today.

Losers

• Applied DNA Sciences (NASDAQ:APDN) stock declined by 13.1% to $3.0 during Monday's pre-market session. The market value of their outstanding shares is at $2.5 million. As per the news, the Q2 earnings report came out yesterday.
• Portage Biotech (NASDAQ:PRTG) shares declined by 12.81% to $0.22. The market value of their outstanding shares is at $4.3 million.
• TransCode Therapeutics (NASDAQ:RNAZ) stock fell 12.06% to $1.24. The market value of their outstanding shares is at $7.5 million.
• Fortrea Holdings (NASDAQ:FTRE) stock fell 9.09% to $30.03. The company's market cap stands at $2.6 billion. The company's, Q1 earnings came out today.
• NovaBay Pharmaceuticals (AMEX:NBY) shares declined by 9.08% to $0.07. The company's market cap stands at $2.6 million. The company's, Q1 earnings came out 2 days ago.
• 60 Degrees (NASDAQ:SXTP) stock decreased by 8.89% to $0.2. The market value of their outstanding shares is at $2.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.